VERACYTE, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VERACYTE, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $193.83M.
- VERACYTE, INC. stock issued during period, value, new issues for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- VERACYTE, INC. stock issued during period, value, new issues for the quarter ending 2019-06-30 was $137.85M.
- VERACYTE, INC. stock issued during period, value, new issues for the quarter ending 2018-09-30 was $55.04M.
- VERACYTE, INC. stock issued during period, value, new issues for fiscal 2013 was $59.16M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2020-09-30 | $193.83M 10-Q · filed 2020-11-02 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | |
| 2019-06-30 | $137.85M 10-Q · filed 2020-07-30 | |
| 2018-09-30 | $55.04M 10-Q · filed 2019-10-22 | |
| 2013-12-31 | $59.16M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |